Figures & data
Figure 1 Algorithm for treatment of hypertension. BP, blood pressure. Modified from CitationChobanian et al (2003).
![Figure 1 Algorithm for treatment of hypertension. BP, blood pressure. Modified from CitationChobanian et al (2003).](/cms/asset/85356386-556e-4160-9d08-9c494e929da2/dvhr_a_2586_f0001_b.jpg)
Figure 2 Effect of fixed-dose combinations versus free-drug combination on the risk of medication nonadherence in cohort with hypertension. Reprinted from CitationBangalore S, Kamalakkannan G, Parkar S, et al 2007. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 120:713–19. Copyright © 2007, with permission from Elsevier.
![Figure 2 Effect of fixed-dose combinations versus free-drug combination on the risk of medication nonadherence in cohort with hypertension. Reprinted from CitationBangalore S, Kamalakkannan G, Parkar S, et al 2007. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 120:713–19. Copyright © 2007, with permission from Elsevier.](/cms/asset/64012167-628f-4eb6-86d4-980e486e03b2/dvhr_a_2586_f0002_b.jpg)
Table 1 Advantages of fixed-dose combination therapy
Figure 3 Medication adherence with combination of amlodipine/benazepril singletablet compared to same combination as separate components.
![Figure 3 Medication adherence with combination of amlodipine/benazepril singletablet compared to same combination as separate components.](/cms/asset/e346f3fd-ef03-4334-b6a8-db3ee906130a/dvhr_a_2586_f0003_b.jpg)
Table 2 Currently available combination antihypertensives in US in 2007
Figure 4 Reduction (model fitted) in seated systolic blood pressure (SBP) (upper panel) and seated diastolic blood pressure (DBP) (lower panel) for 12 groups in the factorial design by olmesartan medoxomil and hydrochlorothiazide (HCTZ) dosage. Adapted by permission from Macmillan Publishers Ltd: CitationChrysant SG, Weber MA, Wang AC, et al 2004. Evaluation of antihypertensive therapy with combination of olmesartan medoxomil and hydrochlorothiazide. Am J Hypertens 17:252-9. Copyright © 2004.
![Figure 4 Reduction (model fitted) in seated systolic blood pressure (SBP) (upper panel) and seated diastolic blood pressure (DBP) (lower panel) for 12 groups in the factorial design by olmesartan medoxomil and hydrochlorothiazide (HCTZ) dosage. Adapted by permission from Macmillan Publishers Ltd: CitationChrysant SG, Weber MA, Wang AC, et al 2004. Evaluation of antihypertensive therapy with combination of olmesartan medoxomil and hydrochlorothiazide. Am J Hypertens 17:252-9. Copyright © 2004.](/cms/asset/0dfb95be-f6ca-471a-8b0b-6e378f8609f5/dvhr_a_2586_f0004_b.jpg)